Home Newsletters Human Immunology News Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient...

Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways

0
Researchers announced the integration of PrismRA® into its clinical pathway for patients living with rheumatoid arthritis. Scipher Medicine, the manufacturer of PrismRA, is a precision immunology company helping providers determine the most effective therapy for their patients.
[Trellis Rx (BusinessWire, Inc.)]
6445218 {6445218:AAAAAAAA} apa 50 1 167698 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Press Release
Exit mobile version